JC
AZN icon

JB Capital’s AstraZeneca AZN Stock Holding History

JB Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,076
Closed -$539K – 164
2022
Q2 		$539K Buy
4,076
+71
+2% +$9.32K 0.06% 148
2022
Q1 		$532K Sell
4,005
-503
-11% -$60.3K 0.05% 156
2021
Q4 		$525K Buy
4,508
+38
+0.9% +$4.47K 0.05% 163
2021
Q3 		$537K Buy
+4,470
New +$520K 0.07% 168

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

JB Capital's AZN Position: Q3 2022 in Review

JB Capital sold out of AstraZeneca (AZN) in Q3 2022, closing a stake of 4,076 shares — an estimated $539K sold.

JB Capital first reported a position in AZN in Q3 2021 and held it in 4 quarters. The position peaked at $539K in Q2 2022. 965 funds tracked by Wall St. Rank hold AZN as of Q3 2022.

  • JB Capital reported no remaining AstraZeneca position as of Q3 2022 after selling out during the quarter.
  • JB Capital sold 4,076 AstraZeneca shares in Q3 2022, an estimated $539K.
  • JB Capital first reported a position in AstraZeneca in Q3 2021 and held it in 4 quarters.
  • JB Capital's AstraZeneca position peaked at $539K in Q2 2022.
  • 965 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2022.

Based on JB Capital's 13F filing for Q3 2022, filed 14 Oct 2022.